The federal health officers are urging all vaccinated adults to get their Covid booster shot amid growing alarm over the omicron variant, a heavily mutated coronavirus strain that’s already been detected in a handful of states across the U.S. Some experts are concerned that future vaccines may be less effective if they receive too many booster doses.

The variant’s mutations suggest it may be able to dodge some of the immunity provided by vaccination or natural infection. Federal health officials, drugmakers and others are still waiting for highly anticipated laboratory results. how much of a threat omicron poses to vaccinesThe best defense against this new strain is the boosters, according to Dr. Anthony Fauci (White House chief medical advisor, epidemiologists, and immunologists).

However, what strategy is best for boosters moving forward? What if boosters will be required for many years, like Albert Bourla (CEO of Pfizer) suggested? Will they have to change?

Research shows that the Covid vaccines increase the levels of antibodies to all variants. Fauci, the director of National Institute for Allergy and Infectious Disease (NIAID), said Friday during the White House Covid-19 Team briefing. It is possible to have at most some level of cross protection if you are vaccinated.

The following week: health minister of IsraelThe third dosage of the drug was first given by the. Pfizer booster shots in summerAccording to, a fourth booster dosage might be required if Covid cases continue to rise.

Pfizer-BioNTech, Moderna and Johnson & Johnson are working on omicron-specific vaccines to use against the new variant if lab tests show significant declines in protection against severe disease, though it could take months before they’re ready to be distributed.

However, some experts are still questioning whether the use of existing vaccines to boost against emerging strains is appropriate. The shots were made to fight the original virus that was identified in 2019.

“The problem is that if you keep priming with a strain and boosting with it, which is basically for an immune response against an ancestral strain of virus, does this reduce your ability to respond to another virus? Paul Offit from Children’s Hospital Philadelphia, is an expert in vaccines.

Offit refers to an immunologists term “original antigenic crime” where the body’s immune systems relies upon the memories of its first encounters with viruses, which can sometimes lead to weaker immunity when confronted by another virus.

Offit is also part of the Food and Drug Administration’s vaccine advisory panel. He cited the example of human papillomavirus (HPV) after an improved vaccine was released that targeted nine different strains instead of four.

You can be sure that all four strains are in your body if you get HPV4 then HPV9 after getting HPV4. [HPV]Also, 4 of them were in [HPV]9 You had an excellent immune response to all four strains but not as much as the five other strains.” he stated.

Offit stated that theoretically, this could also be true for Covid.

Experts have suggested that it might be best for people not at risk of serious disease to hold off until they can get an injection.

He, along with Philip Krause and Marion Gruber, two former FDA officials, wrote an op-ed published Monday in The Washington Post They argued booster shots should only be given to people at risk of severe diseases, such as elderly or those working in high-risk environments like the health care sector. According to them, the original two doses for the mRNA vaccines work well in healthy adults.

Michael Osterholm, an epidemiologist and former Covid adviser to President Joe Biden, countered that the third dose of mRNA or second dose of J&J should be considered part of the original vaccine’s primary series and people should get a booster as soon as eligible. Osterholm stated that a booster dose could “actually offset immune evasion seen with this particular variant,” to MSNBC’s Hallie Jack on Friday.

Ali Ellebedy (associate professor of pathology, immunology, Washington University School of Medicine St. Louis) pointed out the following: Having too many antibodies against past strains of influenza can cause interference with vaccinations against newer flu varieties.

He said that he does not believe this will happen to Covid at the moment.

According to him, the world’s population doesn’t have sufficient baseline antibodies against SARS/CoV-2 “to stop any further booster,” which can be seen in some cases of flu. He noted that the influenza vaccines, which are not immune-friendly like the mRNA ones, were “poorly immunogenic.”

Yale University’s immunologist Ellen Foxman stated that although boosting with an original vaccine may make subsequent vaccines less effective it is still not wise to wait for a variant-specific shot. According to Foxman, the most important thing is that a potentially deadly disease continues to spread across the nation and existing vaccines can protect you from it.

Is the current shot as effective as the one against the virus? She stated, “Maybe or not. However, it will likely provide at least some resistance against it.”

She said, “If we had known that we would need an updated booster, and knew it was coming out next week,” The truth is that this coronavirus virus, mostly the delta variety, is out there now.

Dr. Peter Hotez agreed and said that the boost shots could have produced a 30-to-40-fold increase in the virus-related antibody levels.

Hotez said, “No matter the outcome, you cannot wait for your booster,” and was codirector of Texas Children’s Hospital’s Center for Vaccine Development and dean of National School of Tropical Medicine at Baylor College of Medicine.

He also said that variant-specific vaccinations may not be required and that drugmakers could fail to create omicron specific boosters.

Hotez explained that there is no guarantee of a slam dunk. Hotez said, “Waiting to get an omicron-specific booster can be a high-risk strategy.”

John Moore is a Professor of Microbiology and Immunology at Weill Cornell Medical College. He said that there were still many unknowns regarding the use of vaccines and the best-boosting strategy will be determined over time.

Everyone wants immediate answers but the truth is that it’s more important to receive the correct answers. He said that it takes time.